Skip to search.
 TSX Down 0.04% TSX Ventures Down 0.04%

VIVUS Inc. (VVUS)

-NasdaqGS
2.46 Down 0.06(2.38%) 4:00PM EDT
|After Hours : 2.50 Up 0.04 (1.63%) 5:16PM EDT
Add to Portfolio
Prev Close:2.52
Open:2.52
Bid:2.50 x 200
Ask:2.57 x 4000
1y Target Est:4.00
Beta:1.1
Earnings Date:May 4 - May 8 (Est.)
Day's Range:2.44 - 2.53
52wk Range:2.41 - 6.28
Volume:1,812,768
Avg Vol (3m):2,525,520
Market Cap:255.55M
P/E (ttm):N/A
EPS (ttm):-0.80
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VVUSDown 2.38%255.55M
LLYDown 1.65%77.05B
GSKDown 2.22%111.01B
PFEDown 0.60%213.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.13
Quarterly EPS Est (Mar-15) :-0.22
Mean Recommendation*:3.3
PEG Ratio (5 yr expected):-0.40

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

VIVUS, Inc., a biopharmaceutical company, develops and commercializes therapies to address unmet needs in obesity, sleep apnea, diabetes, and sexual health in the United States and the European Union. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback